Search results
The FDA should stop letting drug companies skip steps - The Boston Globe
The Boston Globe· 19 hours agoThe FDA approves some new medical treatments quickly, before confirmatory trials are carried out, to...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
AOL· 3 hours agoThe two votes — one for the treatment’s efficacy and one for its safety, by the agency’s Psychopharmacologic Drugs Advisory Committee — marked the first time that FDA advisers ...
FDA advisers consider MDMA therapy to treat PTSD
WKBT La Crosse· 8 hours agoClick here to view this video from News8000.com.
FDA advisers vote against first MDMA therapy to treat PTSD – KION546
KION 46 Salinas· 14 hours agoAfter hearing presentations from the US Food and Drug Administration, treatment sponsor Lykos...
FDA advisers consider MDMA therapy to treat PTSD
WKBT La Crosse· 14 hours agoIt’s the first time the FDA’s advisers have considered a psychedelic drug for medical use. The novel treatment has the potential to transform a field...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
Detroit News· 7 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
FDA Platform Technology Designation Program aims to speed development of drugs, biological products...
JD Supra· 19 hours agoFDA developed the new platform technology designation program draft guidance to fulfill its requirement under Section 506K(b) of the Federal Food, Drug, and Cosmetic Act ( ...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
WSB Radio· 19 minutes agoWASHINGTON — (AP) — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a...
BAI, FDA in tieup to accelerate vaccine testing - BusinessWorld Online
BusinessWorld· 13 hours agoTHE Bureau of Animal Industry (BAI) and the Food and Drug Administration (FDA) signed a memorandum...
Ecstasy as a PTSD treatment gets thumbs down from FDA advisers
Market Watch· 9 hours agoIn votes taken late Tuesday, the majority of the FDA advisory panel’s members said the available...